6月5日，库珀医疗夜盘上涨6.42%，报66.0美元/股，成交额3300.0美元。
消息面上，公司最新公布的财年第二季度业绩全面超出华尔街预期，成为股价上涨的主要推动力。具体来看，截至4月30日的第二季度调整后每股收益为1.21美元，较去年同期的0.96美元增长26%，远超分析师预期的1.10美元；营收达10.82亿美元，同比增长约8%，亦高于市场预期的10.54亿美元。业绩超预期主要得益于隐形眼镜业务的强劲需求。
此外，公司更新全年指引，预计非GAAP每股收益为4.58至4.66美元，营收为42.85亿至43.21亿美元，基本符合市场预期。公司还宣布已就旗下库珀外科部门相关索赔达成解决方案，消除了部分不确定性。
库珀医疗是一家全球性医疗器械公司，旗下CooperVision从事隐形眼镜制造，CooperSurgical专注于生育和妇女健康领域。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.